Gregg Sterling

Gregg Sterling has extensive experience in the pharmaceutical and healthcare sectors, primarily with Eli Lilly and Company from January 2018 to May 2024, where key roles included Senior Director of US Sales Training and Effectiveness for Connected Care and Insulins and Executive Business Director for the Neuroscience Specialty. In these positions, Gregg focused on business analysis and account management, and led initiatives to launch new migraine medications, managing specialty sales representatives for optimal performance. Prior to this, Gregg served as Director of Admissions at Ridge Crest Nursing and Rehabilitation Facility from January 1996 to January 1998, where responsibilities included collaborating with administration and physicians to facilitate patient admissions and developing accreditation policies. Educationally, Gregg holds a Bachelor's degree in Health Policy and Administration from Penn State University, obtained in May 1996, with involvement in Phi Chi Theta Business Fraternity and Dance Marathon during studies.